ID

43618

Beskrivning

Trastuzumab in Treating Women With Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00896376

Länk

https://clinicaltrials.gov/show/NCT00896376

Nyckelord

Versioner (2)
  1. 2017-01-18 2017-01-18 -
  2. 2021-09-20 2021-09-20 -
Uppladdad den

20 september 2021

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Breast Cancer NCT00896376

Engelsk

Eligibility Breast Cancer NCT00896376

1 Formulär  
Criteria
Beskrivning

Criteria

histologically confirmed breast cancer
Beskrivning

Breast Carcinoma

Datatyp

boolean

Alias
UMLS CUI [1]
C0678222
metastatic disease, defined by the existence of a secondary tumor localization radiologically (i.e., by radiography, ct scan, mri scan, or ultrasound) or scintigraphically confrimed
Beskrivning

Neoplasm Metastasis | Secondary Neoplasm Localization Diagnostic radiologic examination | Radiography | CT scan | MRI Scan | Ultrasonography | Scintigraphy

Datatyp

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2,1]
C2939419
UMLS CUI [2,2]
C0475264
UMLS CUI [2,3]
C0043299
UMLS CUI [3]
C0034571
UMLS CUI [4]
C0040405
UMLS CUI [5]
C0917711
UMLS CUI [6]
C0041618
UMLS CUI [7]
C0034606
evaluable disease
Beskrivning

Evaluable Disease

Datatyp

boolean

Alias
UMLS CUI [1]
C1516986
beginning first-line metastatic treatment with trastuzumab (herceptin®) with or without chemotherapy
Beskrivning

First line treatment Neoplasm Metastasis | trastuzumab | Herceptin | Chemotherapy

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1708063
UMLS CUI [1,2]
C0027627
UMLS CUI [2]
C0728747
UMLS CUI [3]
C0338204
UMLS CUI [4]
C0392920
primary tumor must overexpress her2 (ihc 3+ or ihc 2+ and fish+ or fish+)
Beskrivning

primary tumor | ERBB2 Protein Overexpression Immunohistochemistry | Fluorescent in Situ Hybridization

Datatyp

boolean

Alias
UMLS CUI [1]
C0677930
UMLS CUI [2,1]
C1515560
UMLS CUI [2,2]
C0021044
UMLS CUI [3]
C0162789
hormone receptor status not specified
Beskrivning

Hormone Receptor Status Unspecified

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0019929
UMLS CUI [1,2]
C0449438
UMLS CUI [1,3]
C0205370
no brain metastasis
Beskrivning

Metastatic malignant neoplasm to brain

Datatyp

boolean

Alias
UMLS CUI [1]
C0220650
patient characteristics:
Beskrivning

Client Characteristics

Datatyp

boolean

Alias
UMLS CUI [1]
C0815172
menopausal status not specified
Beskrivning

Menopausal Status Unspecified

Datatyp

boolean

Alias
UMLS CUI [1,1]
C3829127
UMLS CUI [1,2]
C0205370
life expectancy > 3 months
Beskrivning

Life Expectancy

Datatyp

boolean

Alias
UMLS CUI [1]
C0023671
able to undergo cardiotoxicity evaluation every 4 months by measuring lvef via an isotopic method or ultrasound with systematic registration
Beskrivning

Cardiotoxicity Evaluation Frequency | Left ventricular ejection fraction Isotopic | Ultrasonography

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0876994
UMLS CUI [1,2]
C1261322
UMLS CUI [1,3]
C0376249
UMLS CUI [2,1]
C0428772
UMLS CUI [2,2]
C4038403
UMLS CUI [3]
C0041618
no chronic uncontrolled disease
Beskrivning

Chronic disease Uncontrolled

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0008679
UMLS CUI [1,2]
C0205318
no heart failure
Beskrivning

Heart failure

Datatyp

boolean

Alias
UMLS CUI [1]
C0018801
no respiratory failure or hypoxemia
Beskrivning

Respiratory Failure | Hypoxemia

Datatyp

boolean

Alias
UMLS CUI [1]
C1145670
UMLS CUI [2]
C0700292
no history of another primary cancer except for basal cell carcinoma of the skin
Beskrivning

Primary malignant neoplasm | Basal cell carcinoma

Datatyp

boolean

Alias
UMLS CUI [1]
C1306459
UMLS CUI [2]
C0007117
no severe uncontrolled infection
Beskrivning

Communicable Disease Uncontrolled Severe

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0205318
UMLS CUI [1,3]
C0205082
no psychological incapacity
Beskrivning

Mental impairment

Datatyp

boolean

Alias
UMLS CUI [1]
C0683322
prior concurrent therapy:
Beskrivning

Therapeutic procedure

Datatyp

boolean

Alias
UMLS CUI [1]
C0087111
see disease characteristics
Beskrivning

disease characteristic

Datatyp

boolean

Alias
UMLS CUI [1]
C0599878
Tillbaka till toppen

Similar models

Eligibility Breast Cancer NCT00896376

1 Formulär
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
Breast Carcinoma
Item
histologically confirmed breast cancer
boolean
C0678222 (UMLS CUI [1])
Neoplasm Metastasis | Secondary Neoplasm Localization Diagnostic radiologic examination | Radiography | CT scan | MRI Scan | Ultrasonography | Scintigraphy
Item
metastatic disease, defined by the existence of a secondary tumor localization radiologically (i.e., by radiography, ct scan, mri scan, or ultrasound) or scintigraphically confrimed
boolean
C0027627 (UMLS CUI [1])
C2939419 (UMLS CUI [2,1])
C0475264 (UMLS CUI [2,2])
C0043299 (UMLS CUI [2,3])
C0034571 (UMLS CUI [3])
C0040405 (UMLS CUI [4])
C0917711 (UMLS CUI [5])
C0041618 (UMLS CUI [6])
C0034606 (UMLS CUI [7])
Evaluable Disease
Item
evaluable disease
boolean
C1516986 (UMLS CUI [1])
First line treatment Neoplasm Metastasis | trastuzumab | Herceptin | Chemotherapy
Item
beginning first-line metastatic treatment with trastuzumab (herceptin®) with or without chemotherapy
boolean
C1708063 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
C0728747 (UMLS CUI [2])
C0338204 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
primary tumor | ERBB2 Protein Overexpression Immunohistochemistry | Fluorescent in Situ Hybridization
Item
primary tumor must overexpress her2 (ihc 3+ or ihc 2+ and fish+ or fish+)
boolean
C0677930 (UMLS CUI [1])
C1515560 (UMLS CUI [2,1])
C0021044 (UMLS CUI [2,2])
C0162789 (UMLS CUI [3])
Hormone Receptor Status Unspecified
Item
hormone receptor status not specified
boolean
C0019929 (UMLS CUI [1,1])
C0449438 (UMLS CUI [1,2])
C0205370 (UMLS CUI [1,3])
Metastatic malignant neoplasm to brain
Item
no brain metastasis
boolean
C0220650 (UMLS CUI [1])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Menopausal Status Unspecified
Item
menopausal status not specified
boolean
C3829127 (UMLS CUI [1,1])
C0205370 (UMLS CUI [1,2])
Life Expectancy
Item
life expectancy > 3 months
boolean
C0023671 (UMLS CUI [1])
Cardiotoxicity Evaluation Frequency | Left ventricular ejection fraction Isotopic | Ultrasonography
Item
able to undergo cardiotoxicity evaluation every 4 months by measuring lvef via an isotopic method or ultrasound with systematic registration
boolean
C0876994 (UMLS CUI [1,1])
C1261322 (UMLS CUI [1,2])
C0376249 (UMLS CUI [1,3])
C0428772 (UMLS CUI [2,1])
C4038403 (UMLS CUI [2,2])
C0041618 (UMLS CUI [3])
Chronic disease Uncontrolled
Item
no chronic uncontrolled disease
boolean
C0008679 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Heart failure
Item
no heart failure
boolean
C0018801 (UMLS CUI [1])
Respiratory Failure | Hypoxemia
Item
no respiratory failure or hypoxemia
boolean
C1145670 (UMLS CUI [1])
C0700292 (UMLS CUI [2])
Primary malignant neoplasm | Basal cell carcinoma
Item
no history of another primary cancer except for basal cell carcinoma of the skin
boolean
C1306459 (UMLS CUI [1])
C0007117 (UMLS CUI [2])
Communicable Disease Uncontrolled Severe
Item
no severe uncontrolled infection
boolean
C0009450 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Mental impairment
Item
no psychological incapacity
boolean
C0683322 (UMLS CUI [1])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
disease characteristic
Item
see disease characteristics
boolean
C0599878 (UMLS CUI [1])
Tillbaka till toppen 

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial